stockrow
Friday 6 November 2026
Export SOPH’s income statement to Excel — free account
SOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024.
- Revenue
- +24.7%
- EPS
- +21.0%
- Free cash flow
- −1.87%
- Total debt
- +1.19%
Quarter to September 2026, against a year earlier
7.09
0.47
+7.10%
Follow SOPH
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 2 | 2 |
+8 more TTM periods Free account |
| (125.67%) | (101.22%) | (123.28%) | (110.00%) | ||
| (46.60%) | (43.02%) | (53.30%) | (49.63%) | ||
ROIC |
(200.89%) | (196.45%) | (160.25%) | (180.23%) | |
Return on Tangible Assets |
(108.19%) | (88.77%) | (149.02%) | (145.71%) | |
Average Days of Receivables |
67.13 | 59.78 | 64.35 | 70.86 | |
Free Cash Flow per Share |
(0.49) | (0.56) | (0.59) | (0.54) | |
Free Cash Flow |
(41.52) | (41.21) | (41.81) | (36.63) | |
Capital Expenditures |
(1.09) | (1.47) | (1.55) | (0.74) | |
| Other line items | |||||
Cash ROIC |
(19.75%) | (17.26%) | (26.31%) | (22.18%) | |
Accounts Receivable Turnover |
7.22 | 7.30 | 6.49 | 6.89 | |
Accounts Payable Turnover |
3.74 | 2.93 | 3.08 | 3.55 | |
Inventory Turnover |
4.41 | 4.32 | 4.38 | 4.12 | |
Average Days of Payables |
122.90 | 151.09 | 174.08 | 129.81 | |
Days of Inventory on Hand |
85.58 | 89.91 | 97.37 | 92.01 | |
Tax Rate |
0.00 | 0.01 | 0.02 | 0.02 | |
Research and Development Expense of Revenue |
38.50% | 40.38% | 42.57% | 44.28% | |
Selling, General and Administrative Expense of Revenue |
108.91% | 111.61% | 113.47% | 114.77% | |
Share Based Compensation of Revenue |
17.84% | 18.36% | 19.32% | 20.97% | |
Interest Coverage |
(11.20) | (11.13) | (12.97) | (15.57) | |
Operating CF/Net income |
0.50 | 0.49 | 0.50 | 0.45 | |
Depreciation/Fixed assets |
2.55 | 2.15 | 1.96 | 1.68 | |
Capex/Depreciation |
(0.10) | (0.14) | (0.15) | (0.08) | |
Revenue per Share |
1.06 | 1.17 | 1.14 | 1.14 | |
Operating CF per Share |
(0.47) | (0.54) | (0.57) | (0.53) | |
Capex per Share |
(0.01) | (0.02) | (0.02) | (0.01) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026